Nasal vaccine devices have the potential to offer more convenient and more effective protection against a variety of viruses.

The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.

The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...

Vistagen Therapeutics, Inc.'s fasedienol shows promise in treating social anxiety; new results expected 2025. Click for my ...

State of Alaska Department of Revenue lessened its holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 1.6% in the fourth quarter, HoldingsChannel reports. The fund owned 21,325 ...

Milestone announced further details on its in-person and virtual Commercial Launch Plan investor event to take place in New York on Tuesday, ...

ARS Pharmaceuticals, Inc. (NASDAQ:SPRY – Get Free Report) has earned a consensus recommendation of “Buy” from the seven research firms that are currently covering the stock, Marketbeat Ratings reports ...

This is the year to be optimistic about Alzheimer’s disease says one of Australia’s leading dementia researchers.

Today the Coalition for Epidemic Preparedness Innovations (CEPI) announced an award of $5 million funding award to Ethris, a ...

Shares of Lupin Ltd dropped 2.8% despite a significant Q3 profit increase of 38.8% year-on-year. The company's revenue surged ...

The Indian stock market is set for an eventful session today, with Gift Nifty opening at 23,485.5 and currently trading 0.06% ...

Virpax Pharmaceuticals, Inc. ("Virpax" or the "Company"), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS) ...